Zelda Therapeutics enters medical cannabis research partnership

Proactive Investors Thursday, 7 December 2017 ()
Zelda Therapeutics Ltd (ASX:ZLD) continues to advance its medical cannabis strategy, and the company entered a trading halt this morning pending details of a partnership with a US-based research institution. READ: Zelda approved for Australia’s first medicinal cannabis trial targeting insomnia The halt will remain in place until the opening of trade on Tuesday 12th December 2017, or earlier if an announcement is made to the market.
👓 View on full article
0
shares		Share on
FacebookShare on
TwitterPost on 
RedditShare by
Email
 
Source: Wochit Business - < > Embed
News video: Ohio Approves Cannabis Growers

Ohio Approves Cannabis Growers 00:40

 Ohio has started it's own medial marijuana program. 12 large growers were picked Thursday to participate in the program pilot. Large growers paid $20,000 in application fees, as well as a $180,000 initial license fee. All of the sites will be indoor, high-security, regulated businesses. Ohio is the...